ATE545414T1 - Zubereitung zur verhinderung der alterungssymptome mit phytoöstrogenen und melatonin - Google Patents

Zubereitung zur verhinderung der alterungssymptome mit phytoöstrogenen und melatonin

Info

Publication number: ATE545414T1
Authority: AT; Austria
Prior art keywords: preparation; melatonin; phytoestrogens; preventing aging; aging symptoms
Prior art date: 2006-07-04

Application number

AT07785895T

Other languages

English (en)

Inventor

Leonardo Cavazzana

Original Assignee

I R Med S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-04

Filing date

2007-07-04

Publication date

2012-03-15

2007-07-04 Application filed by I R Med S R L filed Critical I R Med S R L

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE545414T1 publication Critical patent/ATE545414T1/de

Links

YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title abstract 2
230000032683 aging Effects 0.000 title abstract 2
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title abstract 2
229960003987 melatonin Drugs 0.000 title abstract 2
239000003075 phytoestrogen Substances 0.000 title 1
235000006539 genistein Nutrition 0.000 abstract 2
TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 abstract 2
229940045109 genistein Drugs 0.000 abstract 2
ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 abstract 2
235000003687 soy isoflavones Nutrition 0.000 abstract 2
230000003280 chronobiological effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Alternative & Traditional Medicine (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT07785895T 2006-07-04 2007-07-04 Zubereitung zur verhinderung der alterungssymptome mit phytoöstrogenen und melatonin ATE545414T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06425463		2006-07-04
PCT/EP2007/005917 WO2008003475A1 (en)	2006-07-04	2007-07-04	Preparation for preventing ageing symptoms containing phytoestrogens and melatonin

Publications (1)

Publication Number	Publication Date
ATE545414T1 true ATE545414T1 (de)	2012-03-15

Family

ID=37434213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07785895T ATE545414T1 (de)	2006-07-04	2007-07-04	Zubereitung zur verhinderung der alterungssymptome mit phytoöstrogenen und melatonin

Country Status (3)

Country	Link
EP (1)	EP2034991B1 (de)
AT (1)	ATE545414T1 (de)
WO (1)	WO2008003475A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5260798A (en) *	1996-11-18	1998-06-10	Internutria, Inc.	Compositions and treatment for nighttime persistent reproductive transition symptoms

2007
- 2007-07-04 EP EP07785895A patent/EP2034991B1/de not_active Not-in-force
- 2007-07-04 WO PCT/EP2007/005917 patent/WO2008003475A1/en not_active Ceased
- 2007-07-04 AT AT07785895T patent/ATE545414T1/de active

Also Published As

Publication number	Publication date
EP2034991A1 (de)	2009-03-18
EP2034991B1 (de)	2012-02-15
WO2008003475A1 (en)	2008-01-10

Similar Documents

Publication	Publication Date	Title
PL1986669T3 (pl)	2012-09-28	Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
ECSP088745A (es)	2008-10-31	Derivados sustituidos de cromanol y su uso
UY30364A1 (es)	2008-01-02	Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
MX2011006224A (es)	2011-08-12	Composicion que comprende isoflavonas.
ECSP077296A (es)	2007-04-26	Fenilaminotiazoles sustituidos y su uso
CO6440531A2 (es)	2012-05-15	2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CY1110170T1 (el)	2015-01-14	Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
IL196745A (en)	2016-10-31	Idabanon for use in providing mucosal pathways to treat disease
UA100542C2 (ru)	2013-01-10	Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
ATE353655T1 (de)	2007-03-15	Myo-inositol hexaphosphat zur topischen verwendung
NO20082636L (no)	2008-09-29	Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme
ATE548349T1 (de)	2012-03-15	In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
ATE443722T1 (de)	2009-10-15	Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung
ATE475651T1 (de)	2010-08-15	Aryl-substituierte heterozyklen und ihre verwendung
ZA201000581B (en)	2011-04-28	1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
MX2009001433A (es)	2009-04-09	Nucleosidos para suprimir o reducir el desarrollo de resistencia en terapia citostatica.
TN2010000266A1 (en)	2011-11-11	Oxazolidinones for the treatment and/or prophylaxis of heart failure
MX2009003676A (es)	2009-07-16	Compuestos s-nitrosotiol y derivados relacionados.
WO2006136428A3 (en)	2007-04-12	Method and composition to treat skin ulcers
ATE477820T1 (de)	2010-09-15	Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
WO2005094798A3 (en)	2006-04-13	Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists
WO2008036157A3 (en)	2008-12-24	Prophylactic and therapeutic treatment of avian influenza infections in animals
ATE508750T1 (de)	2011-05-15	Derivate von vitamin d und ihre verwendung in der therapie
EP1941894A4 (de)	2012-04-04	Isoflavon-zusammensetzung zur behandlung von menopausalen physiologischen störungen und symptomen
BRPI0518885A2 (pt)	2008-12-16	uso de derivados de estaurosporina para o tratamento de mieloma méltiplo